Insulin-like growth factor-II mRNA binding protein 3 (199-207)

Insulin-like growth factor-II mRNA binding protein 3 (199-207) is a synthetic peptide fragment derived from the larger IGF2BP3 protein, a member of the insulin-like growth factor-II mRNA binding protein family known for its regulatory role in post-transcriptional gene expression. This peptide corresponds to amino acid residues 199 to 207 within the IGF2BP3 sequence, a region that may be involved in RNA-binding or protein-protein interactions pertinent to cellular growth and differentiation. As a research peptide, it is primarily utilized in studies investigating the molecular mechanisms of RNA regulation, signal transduction, and the functional domains of RNA-binding proteins, offering a focused tool for dissecting the biological roles of IGF2BP3 in various cellular contexts.

Peptide-Protein Interaction Studies: Researchers frequently use this peptide fragment to probe the specific binding interactions between IGF2BP3 and its molecular partners. By isolating the 199-207 region, scientists can map interaction sites and assess the contribution of this domain to the protein's affinity for target RNAs or co-factors. Such studies are vital for elucidating the modular structure of IGF2BP3 and understanding how discrete peptide segments influence its biological activity within the cell.

Functional Domain Mapping: The 199-207 peptide serves as a valuable reagent for identifying functional motifs within IGF2BP3. By employing techniques such as peptide competition assays or site-directed mutagenesis, investigators can determine the significance of this sequence in RNA recognition or regulatory functions. Insights gained from these experiments help clarify the structure-function relationships that underpin the protein's involvement in mRNA stabilization, localization, and translation control.

Antibody Generation and Epitope Mapping: The defined sequence of the peptide makes it an ideal immunogen for generating site-specific antibodies against IGF2BP3. Such antibodies are critical for detecting the native protein in immunoassays, immunoprecipitation, or immunohistochemistry applications. Additionally, the peptide can be used in epitope mapping studies to characterize antibody specificity, supporting the development of reliable detection tools for basic and applied research.

Phosphorylation and Post-Translational Modification Analysis: The synthetic peptide provides a controlled substrate for in vitro kinase assays or mass spectrometry-based studies aimed at identifying post-translational modifications within the 199-207 region. By examining how this segment is modified under different experimental conditions, researchers can gain insights into regulatory mechanisms affecting IGF2BP3 function and its downstream signaling pathways.

Peptide-Based Inhibitor Screening: In drug discovery and molecular probe development, the 199-207 fragment can be employed in high-throughput screening assays to identify small molecules or peptides capable of disrupting IGF2BP3 interactions. By targeting this specific region, scientists aim to modulate the activity of the full-length protein, providing a foundation for the development of novel research tools or chemical probes that selectively influence RNA-binding protein networks.

1. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I